Barclays PLC 23and Me Holding Co. Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in 23and Me Holding Co. stock. As of the latest transaction made, Barclays PLC holds 274,332 shares of ME stock, worth $150,882. This represents 0.0% of its overall portfolio holdings.
Number of Shares
274,332
Previous 472,960
42.0%
Holding current value
$150,882
Previous $432,000
66.2%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ME
# of Institutions
161Shares Held
122MCall Options Held
197KPut Options Held
229K-
Black Rock Inc. New York, NY21.6MShares$11.9 Million0.0% of portfolio
-
New View Capital Partners I, LLC Burlingame, CA19.5MShares$10.7 Million8.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.3MShares$8.97 Million0.0% of portfolio
-
Euclidean Capital LLC New York, NY10.2MShares$5.63 Million0.7% of portfolio
-
Geode Capital Management, LLC Boston, MA7.48MShares$4.12 Million0.0% of portfolio
About 23andMe Holding Co.
- Ticker ME
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 259,768,000
- Market Cap $143M
- Description
- 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...